北美分析实验室服务市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美分析实验室服务市场 – 行业趋势和 2029 年预测

  • Medical Devices
  • Published Report
  • Sep 2022
  • North America
  • 350 页面
  • 桌子數: 78
  • 图号: 47

>北美分析实验室服务市场,按测试类型(生物分析测试、批量放行测试、稳定性测试、原材料测试、物理特性、方法验证、微生物测试、环境监测)、服务类型(医院实验室、独立实验室和诊所实验室)、方法类型(基于细胞的测定、病毒学测试、生物标志物测试、药代动力学测试、免疫原性和血清学)、应用(肿瘤学、神经病学、传染病、胃肠病学、心脏病学和其他应用)、技术(质谱(LC-MS/MS)、免疫化学、UPLC 技术、湍流技术、其他)、最终用户渠道(制药和生物制药公司、合同开发和制造组织、合同研究组织等)划分 - 行业趋势和预测到 2029 年。

分析实验室服务市场

北美分析实验室服务市场分析和规模

市场上提供多种分析服务,例如生物分析测试、原材料测试、批次放行测试、产品验证、物理特性等。这些服务广泛应用于医疗保健领域,包括制药公司、生物制药公司和医疗器械公司。这些服务为准确性、质量和效率提供了可靠的来源。它们应用于肿瘤学、神经病学、传染病、心脏病学等领域。随着政府加强分析测试能力的举措增多以及药品批准和临床试验数量的增加,分析实验室服务市场正在增长。此外,各种治疗领域大量大分子和生物仿制药的使用和开发增加以及政府增加建立新实验室的支出也是加速实验室服务市场增长的其他因素。

分析实验室服务市场

分析实验室服务市场

Data Bridge Market Research 分析称,到 2029 年,分析实验室服务市场预计将达到 75.3576 亿美元的价值,预测期内的复合年增长率为 14.1%。生物分析测试部分是分析实验室服务市场中最大的供应部分。分析实验室服务市场报告还详细介绍了定价分析、专利分析和技术进步。

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制 2019-2014)

定量单位

收入(百万美元),定价(美元)

涵盖的领域

By Test Type (Bioanalytical Testing, Batch Release Testing, Stability Testing, Raw Material Testing, Physical Characterization, Method Validation, Microbial Testing, Environmental Monitoring), Service Type (Hospital-Based Laboratories, Stand-Alone Laboratories and Clinics-Based Laboratories), Method Type (Cell-Based Assays, Virology Testing, Biomarker Testing, Pharmacokinetic Testing, Immunogenicity and Serology), Application (Oncology, Neurology, Infectious disease, Gastroenterology, Cardiology and Other Applications), Technology (Mass Spectroscopy (LC-MS/MS), Immunochemistry, UPLC Technology, Turbulent Flow Technology, Others), End User Channel (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, Contract Research Organizations and Others)

Countries Covered

U.S., Canada, and Mexico

Market Players Covered

Charles River Laboratories, Medpace, WuXi AppTec, Eurofins Scientific, Q2 Solutions (A Subsidiary of IQVIA), SGS SA, SOLVIAS AG, Syneos Health, ICON plc, Frontage Labs, TOXIKON, BioAgilytix Labs, VxP Pharma, Inc., Pace Analytical Services, LLC, Pharmaceutical Research Associates Inc., ALS Limited, Evotec SE, Intertek Group plc, Covance (A Subsidiary of Laboratory Corporation of America), and PPD Inc. (a subsidiary of Thermo Fisher Scientific Inc.) among others

Market Definition

Analytical laboratory services are concerned with a wide range of chemical and microbiological assays. Analytical laboratory services include method development and validation, sample analysis for concentration confirmation, purity, homogeneity, and stability assays on preliminary formulations and finalized drug products for IND, NDA, and ANDA submissions. Analytical services, also referred to as "materials testing," is used to describe various techniques used to identify the chemical makeup or characteristics of a particular sample. Manufacturers in industries such as pharmaceuticals, food, electronics, and plastics often use analytical testing for reverse engineering or failure analysis and identifying contaminants or stains on products

Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

  • Growing expenditure on drugs and medical devices

The rise of pharmaceutical and biotechnological industries will increase the market for these analytical services as they are dependent on drug markets to provide services such as pharmacokinetic testing and other batch testing and microbial testing. Therefore, it is expected to act as a driver for the growth of the North America analytical laboratory services market in the forecast period.

  • Government initiatives to strengthen analytical testing capabilities

Government funding and initiative to expand the analytical services will help the market grow and increase the market players in the forecast period. This is expected to increase the market size and act as a driver for the growth of the North America analytical laboratory services market in the forecast period.

  • Increasing number of drug approvals and clinical trials

The market players give the analytical testing process under contract research. Furthermore, the increasing biopharmaceutical industry with increased drug production and research for novel products is expected to act as a driver for the growth of the North America analytical laboratory services market in the forecast period.

Opportunities

  • Increasing collaboration among market players

Collaborations in the market is the primary factor that is expected to create opportunities in the market. Agreements, partnerships, and collaborations are performed to overcome hurdles such as limited global presence and supply chain and to increase the service portfolio. In the analytical laboratory services market, various market players have performed this, creating opportunities in the market.

Restraints/Challenges

  • High cost setting of an advanced analytical lab

The considerable investment needed to set up a bioanalytical facility with a limited and highly efficient instrument is expected to limit the market growth due to high investment costs. This is expected to act as a restraint on the growth of the North America analytical laboratory services market in the forecast period.

COVID-19 Impact on North America Analytical Laboratory Services Market

COVID-19 created a major impact on various industries as almost every country has opted for the shutdown of every facility except the ones dealing in the essential goods segment. The government took some strict actions, such as the shutdown of facilities and sale of non-essential goods, blocked international trade, and many more, to prevent the spread of COVID-19. The only business dealing with this pandemic situation were the essential services allowed to open and run the processes.

The diversion of resources to treat COVID-19 patients has significantly impacted the operations at most of the investigative sites where patients in the clinical trials are recruited and treated. These analytical services are extensively used in clinical trials for different bioanalytical studies. Moreover, this has resulted in reduced trial starts and slowed new business awards, each of which results in decreased revenues for various companies.

COVID-19 has impacted the market of analytical laboratory services negatively. Due to the cancellation of the clinical trial, the demand for analytical services was also disrupted. The major portion of these analytical services comes from the clinical trials and CRO, which get badly impacted. However, some of the market players, such as Eurofins Scientific, which can provide analytical support, were successful in minimizing the loss during COVID-19. The supply chain was disrupted as the material and solvent that were mandatory for these analytical testing faced challenges in the customs department and were not allowed to cross international borders.

Hence, COVID-19 has negatively impacted the analytical testing business, but the strategic initiative of the market players is somehow gaining success in minimizing the loss in the net revenue or segmental revenue.

Recent Developments

  • In February 2021, Eurofins Scientific announced that they had acquired Beacon Discovery, preeminent drug discovery and contract research organization (CRO). This will increase the company's access to contract research and will increase its revenue for the company
  • In April 2021, SGS SA announced that the company SYNLAB Analytics & Services is now be called SGS Analytics which is due to the acquisition of the leading European environmental, food & health sciences testing and tribology services company. The acquisition will continue growth and innovation by helping businesses to comply with ever increasing regulations designed to ensure food, pharmaceutical, and environmental safety

North America Analytical Laboratory Services Market Scope

The analytical laboratory services market is segmented on the basis of test type, service type, method type, application, technology, and end users. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

By Test Type

  • Bioanalytical testing
  • Batch release testing
  • Method validation
  • Raw material testing
  • Microbial testing
  • Physical characterization
  • Stability testing
  • Environmental monitoring

On the basis of test type, the analytical laboratory services market is segmented into bioanalytical testing, batch release testing, stability testing, raw material testing, physical characterization, method validation, microbial testing and environmental monitoring.

By Service Type

  • Hospital-based laboratories
  • Stand-alone laboratories
  • Clinics-based laboratories

On the basis of service type, the analytical laboratory services market is segmented into hospital-based laboratories, stand-alone laboratories and clinic-based laboratories.

By Method Type

  • Pharmacokinetic testing
  • Biomarker testing
  • Virology testing
  • Cell-based assays
  • Immunogenicity
  • Serology

根据方法类型,分析实验室服务市场分为基于细胞的分析、病毒学测试、生物标志物测试、药代动力学测试、免疫原性和血清学。

按应用

  • 肿瘤学
  • 神经病学
  • 传染病
  • 心脏病学
  • 胃肠病学
  • 其他的

根据应用,分析实验室服务市场细分为肿瘤学、神经病学、传染病、胃肠病学、心脏病学和其他应用。

按技术分类

  • 质谱
  • 免疫化学
  • UPLC 技术
  • 湍流技术
  • 其他的

根据技术,分析实验室服务市场细分为质谱、免疫化学、UPLC 技术、湍流技术和其他技术。

按最终用户

  • 制药和生物制药公司
  • 合同开发和制造组织
  • 合同研究组织
  • 其他的

分析实验室服务市场

根据最终用户,分析实验室服务市场分为制药和生物制药行业、合同开发和制造组织、合同研究组织和其他。

分析实验室服务市场区域分析/见解

对分析实验室服务市场进行了分析,并按上述国家、测试类型、服务类型、方法类型、应用、技术和最终用户提供了市场规模洞察和趋势。

分析实验室服务市场报告涵盖的国家包括美国、加拿大和墨西哥。

由于该地区实验室的不断发展,美国预计将主导北美分析实验室服务市场。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析以及案例研究等数据点是用于预测各个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。

竞争格局和分析实验室服务市场份额分析

分析实验室服务市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对分析实验室服务市场的关注有关。

在北美分析实验室服务市场提供分析实验室服务的一些主要公司包括 Charles River Laboratories、Medpace、WuXi AppTec、Eurofins Scientific、Q2 Solutions(IQVIA 的子公司)、SGS SA、SOLVIAS AG、Syneos Health、ICON plc、Frontage Labs、TOXIKON、BioAgilytix Labs、VxP Pharma, Inc.、Pace Analytical Services, LLC、Pharmaceutical Research Associates Inc.、ALS Limited、Evotec SE、Intertek Group plc、Covance(Laboratory Corporation of America 的子公司)和 PPD Inc.(Thermo Fisher Scientific Inc. 的子公司)等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 DBMR MARKET POSITION GRID

2.8 VENDOR SHARE ANALYSIS

2.9 MARKET TYPE OF MANUFACTURER COVERAGE GRID

2.1 MULTIVARIATE MODELLING

2.11 TEST TYPE LIFELINE CURVE

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 REGULATORY SCENARIO IN NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 GROWING EXPENDITURE ON DRUGS AND MEDICAL DEVICES

5.1.2 GOVERNMENT INITIATIVES TO STRENGTHEN ANALYTICAL TESTING CAPABILITIES

5.1.3 INCREASING NUMBER OF DRUG APPROVALS & CLINICAL TRIALS

5.1.4 RISING DEMAND FOR SPECIALIZED ANALYTICAL TESTING SERVICES

5.1.5 INCREASING INVESTMENT IN ANALYTICAL TESTING BY MARKET PLAYERS

5.2 RESTRAINTS

5.2.1 LIMITATION IN ANALYZING NOVEL COMPLEX PRODUCTS

5.2.2 COST OF LABORATORY TESTING FOR DRUG DEVELOPMENT

5.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT

5.2.4 HIGH COST SETTING AN ADVANCED ANALYTICAL LAB

5.3 OPPORTUNITIES

5.3.1 INCREASING COLLABORATION AMONG MARKET PLAYERS

5.3.2 INCREASING OUTSOURCING FACILITIES

5.3.3 INCREASING TREND OF ARTIFICIAL INTELLIGENCE IN TESTING SERVICES

5.4 CHALLENGES

5.4.1 MAINTAINING REGULATORY STANDARD FOR TESTING

5.4.2 DEVELOPMENT AND MAINTENANCE OF EXPERTISE

6 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE

6.1 OVERVIEW

6.2 CELL-BASED ASSAYS

6.3 VIRAL CELL-BASED ASSAYS

6.4 BACTERIAL CELL-BASED ASSAYS

6.5 VIROLOGY TESTING

6.6 IN VITRO VIROLOGY TESTING

6.7 IN VIVO VIROLOGY TESTING

6.8 SPECIES-SPECIFIC VIRAL PCR ASSAYS

6.9 SEROLOGY

6.1 IMMUNOGENICITY

6.11 BIOMARKER TESTING

6.12 PHARMACOKINETIC TESTING

7 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE

7.1 OVERVIEW

7.2 BIOANALYTICAL TESTING

7.2.1 PHARMACOKINETIC TEST

7.2.2 PHARMACODYNAMICS TEST

7.2.3 BIOEQUIVALENCE TEST

7.2.4 BIOAVAILABILITY TEST

7.2.5 OTHER TEST

7.3 BATCH RELEASE TESTING

7.4 STABILITY TESTING

7.5 RAW MATERIAL TESTING

7.6 PHYSICAL CHARACTERIZATION

7.7 METHOD VALIDATION

7.8 MICROBIAL TESTING

7.9 ENVIRONMENTAL MONITORING

8 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 MASS SPECTROSCOPY (LC-MS/MS)

8.3 IMMUNOCHEMISTRY

8.4 UPLC TECHNOLOGY

8.5 TURBULENT FLOW TECHNOLOGY

8.6 OTHERS

9 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE

9.1 OVERVIEW

9.2 HOSPITAL-BASED LABORATORIES

9.3 STANDALONE LAORATORIES

9.4 CLINICS-BASED LABORATORIES

10 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 ONCOLOGY

10.3 INFECTIOUS DISEASES

10.4 NEUROLOGY

10.5 CARDIOLOGY

10.6 GASTROENTEROLOGY

10.7 OTHER APPLICATIONS

11 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY END USER

11.1 OVERVIEW

11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES

11.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS

11.4 CONTRACT RESEARCH ORGANIZATIONS

11.5 OTHERS

12 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY REGION

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 EUROFINS SCIENTIFIC

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 SERVICE PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 CHARLES RIVER LABORATORIES

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 SGS SA

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENTS

15.4 COVANCE (A SUBSIDIARY OF LABORATORY CORPORATION OF AMERICA HOLDINGS)

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 SERVICE PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 WUXI APPTEC

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENTS

15.6 SYNEOS HEALTH

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 SOLUTION PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 PHARMACEUTICAL RESEARCH ASSOCIATES INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 SERVICE PORTFOLIO

15.7.3 RECENT DEVELOPMENTS

15.8 AGENZIA ITALIANA DEL FARMACO - AIFA

15.8.1 COMPANY SNAPSHOT

15.8.2 SERVICE PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 ALS LIMITED

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.9.4 RECENT DEVELOPMENTS

15.1 BIOAGILYTIX LABS

15.10.1 COMPANY SNAPSHOT

15.10.2 SERVICE PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 CENTRAL DRUGS STANDARD CONTROL ORGANIZATION

15.11.1 COMPANY SNAPSHOT

15.11.2 SERVICE PORTFOLIO

15.11.3 RECENT DEVELOPMENT

15.12 EUROPEAN MEDICINES AGENCY

15.12.1 COMPANY SNAPSHOT

15.12.2 SERVICE PORTFOLIO

15.12.3 RECENT DEVELOPMENTS

15.13 EVOTEC SE

15.13.1 COMPANY SNAPSHOT

15.13.2 REVENUE ANALYSIS

15.13.3 PRODUCT PORTFOLIO

15.13.4 RECENT DEVELOPMENTS

15.14 FEDERAL INSTITUTE FOR DRUGS & MEDICAL DEVICES (BFARM)

15.14.1 COMPANY SNAPSHOT

15.14.2 SERVICE PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 FOOD SAFETY AND DRUG ADMINISTRATION DEPARTMENT

15.15.1 COMPANY SNAPSHOT

15.15.2 SERVICE PORTFOLIO

15.15.3 RECENT DEVELOPMENTS

15.16 FRONTAGE LABS

15.16.1 COMPANY SNAPSHOT

15.16.2 REVENUE ANALYSIS

15.16.3 SERVICE & SOLUTION PORTFOLIO

15.16.4 RECENT DEVELOPMENTS

15.17 ICON PLC

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENTS

15.18 INTERTEK GROUP PLC

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 INDUSTRY & SERVICE PORTFOLIO

15.18.4 RECENT DEVELOPMENTS

15.19 MEDPACE

15.19.1 COMPANY SNAPSHOT

15.19.2 REVENUE ANALYSIS

15.19.3 PRODUCT PORTFOLIO

15.19.4 RECENT DEVELOPMENTS

15.2 NATIONAL MEDICAL PRODUCTS ADMINISTRATION

15.20.1 COMPANY SNAPSHOT

15.20.2 SERVICE PORTFOLIO

15.20.3 RECENT DEVELOPMENT

15.21 PACE ANALYTICAL SERVICES, LLC

15.21.1 COMPANY SNAPSHOT

15.21.2 SERVICE PORTFOLIO

15.21.3 RECENT DEVELOPMENTS

15.22 PHARMACEUTICALS AND MEDICAL DEVICES AGENCY

15.22.1 COMPANY SNAPSHOT

15.22.2 PRODUCT PORTFOLIO

15.22.3 RECENT DEVELOPMENT

15.23 PPD INC. (A SUBSIDIARY OF THERMO FISHER SCIENTIFIC INC.)

15.23.1 COMPANY SNAPSHOT

15.23.2 REVENUE ANALYSIS

15.23.3 SOLUTION PORTFOLIO

15.23.4 RECENT DEVELOPMENTS

15.24 Q2 SOLUTIONS (A SUBSIDIARY OF IQVIA)

15.24.1 COMPANY SNAPSHOT

15.24.2 SOLUTION PORTFOLIO

15.24.3 RECENT DEVELOPMENTS

15.25 SHANGHAI MEDICILON INC.

15.25.1 COMPANY SNAPSHOT

15.25.2 SERVICE PORTFOLIO

15.25.3 RECENT DEVELOPMENTS

15.26 SPANISH AGENCY FOR MEDICINES AND HEALTH PRODUCTS

15.26.1 COMPANY SNAPSHOT

15.26.2 SERVICE PORTFOLIO

15.26.3 RECENT DEVELOPMENT

15.27 SOLVIAS AG

15.27.1 COMPANY SNAPSHOT

15.27.2 SERVICE PORTFOLIO

15.27.3 RECENT DEVELOPMENTS

15.28 TOXIKON

15.28.1 COMPANY SNAPSHOT

15.28.2 SERVICE PORTFOLIO

15.28.3 RECENT DEVELOPMENTS

15.29 VXP PHARMA, INC.

15.29.1 COMPANY SNAPSHOT

15.29.2 SERVICE PORTFOLIO

15.29.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

表格列表

TABLE 1 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 2 NORTH AMERICA CELL-BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 NORTH AMERICA CELL BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 4 NORTH AMERICA VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 NORTH AMERICA VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 6 NORTH AMERICA SEROLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 NORTH AMERICA IMMUNOGENICITY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 NORTH AMERICA BIOMARKER TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 NORTH AMERICA PHARMACOKINETIC TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 11 NORTH AMERICA BIOANALYTICAL IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 NORTH AMERICA BIOANALYTICAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 13 NORTH AMERICA BATCH RELEASE IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 NORTH AMERICA STABILITY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 NORTH AMERICA RAW MATERIAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 NORTH AMERICA PHYSICAL CHARACTERIZATION IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 NORTH AMERICA METHOD VALIDATION IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 NORTH AMERICA MICROBIAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 NORTH AMERICA ENVIRONMENTAL MONITORING IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 21 NORTH AMERICA MASS SPECTROMETRY (LC-MS/MS) IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 NORTH AMERICA IMMUNOCHEMISTRY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 NORTH AMERICA UPLC TECHNOLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 NORTH AMERICA TURBULENT FLOW TECHNOLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 NORTH AMERICA OTHERS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION)

TABLE 27 NORTH AMERICA HOSPITAL-BASED LABORATORIES IN ANALYTICAL LABORATORIES SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 NORTH AMERICA STANDALONE LABORATORIES IN ANALYTICAL LABORATORIES SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 NORTH AMERICA CLINICAL-BASED LABORATORIES IN ANALYTICAL LABORATORIES SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 31 NORTH AMERICA ONCOLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 NORTH AMERICA INFECTIOUS DISEASES IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 NORTH AMERICA NEUROLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 NORTH AMERICA CARDIOLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA GASTROENTEROLOGY IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA OTHER APPLICATIONS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 38 NORTH AMERICA PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 NORTH AMERICA CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 NORTH AMERICA OTHERS IN ANALYTICAL LABORATORY SERVICES MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 43 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA BIOANALYTICAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 45 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION)

TABLE 46 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 47 NORTH AMERICA CELL BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 48 NORTH AMERICA VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 49 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 50 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 51 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 52 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 53 U.S. BIOANALYTICAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 54 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION)

TABLE 55 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 56 U.S. CELL BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 57 U.S. VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 58 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 59 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 60 U.S. ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 61 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 62 CANADA BIOANALYTICAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 63 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION)

TABLE 64 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 65 CANADA CELL BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 66 CANADA VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 67 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 68 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 69 CANADA ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 70 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 71 MEXICO BIOANALYTICAL TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2020-2029 (USD MILLION)

TABLE 72 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2020-2029 (USD MILLION)

TABLE 73 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 74 MEXICO CELL BASED ASSAYS IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 75 MEXICO VIROLOGY TESTING IN ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2020-2029 (USD MILLION)

TABLE 76 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 77 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 78 MEXICO ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: MARKET TYPE COVERAGE GRID

FIGURE 10 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: MULTIVARIATE MODELLING

FIGURE 11 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: SEGMENTATION

FIGURE 12 GROWING EXPENDITURE ON DRUGS IS DRIVING THE NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 13 ANALYTICAL LABORATORY TESTING SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET IN 2022 & 2029

FIGURE 14 OVERVIEW OF DIFFERENT GUIDELINES AROUND THE GLOBE

FIGURE 15 CGMP REQUIREMENT FOR ANALYTICAL LABORATORY INCLUDES

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET

FIGURE 17 INCREASING PRESCRIPTION OF DRUGS

FIGURE 18 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY METHOD TYPE, 2021

FIGURE 19 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY METHOD TYPE, 2021-2029 (USD MILLION)

FIGURE 20 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY METHOD TYPE, CAGR (2021-2029)

FIGURE 21 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY METHOD TYPE, LIFELINE CURVE

FIGURE 22 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TEST TYPE, 2021

FIGURE 23 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TEST TYPE 2021-2029 (USD MILLION)

FIGURE 24 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TEST TYPE, CAGR (2021-2029)

FIGURE 25 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 26 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY TECHNOLOGY, 2021

FIGURE 27 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TECHNOLOGY, 2021-2029 (USD MILLION)

FIGURE 28 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TECHNOLOGY, CAGR (2021-2029)

FIGURE 29 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TECHNOLOGY, LIFELINE CURVE

FIGURE 30 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2021 (USD MILLION)

FIGURE 31 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2021-2029 (USD MILLION)

FIGURE 32 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, CAGR (2021-2029)

FIGURE 33 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, LIFELINE CURVE

FIGURE 34 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2021 (USD MILLION)

FIGURE 35 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2021-2029 (USD MILLION)

FIGURE 36 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY APPLICATION, CAGR (2021-2029)

FIGURE 37 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY APPLICATION , LIFELINE CURVE

FIGURE 38 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET, BY END USER, 2021

FIGURE 39 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY END USER, 2021-2029 (USD MILLION)

FIGURE 40 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY END USER, CAGR (2021-2029)

FIGURE 41 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 42 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: SNAPSHOT (2021)

FIGURE 43 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY COUNTRY (2021)

FIGURE 44 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 45 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 46 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: BY TEST TYPE (2022-2029)

FIGURE 47 NORTH AMERICA ANALYTICAL LABORATORY SERVICES MARKET: COMPANY SHARE 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The growth forecast of the North America Analytical Laboratory Services Market will surge at a 14.1% CAGR by 2029.
The North America Analytical Laboratory Services Market is to reach a value of USD 7,535.76 million by 2029
The major players in the market are Charles River Laboratories, Medpace, WuXi AppTec, Eurofins Scientific, Q2 Solutions (A Subsidiary of IQVIA), SGS SA, SOLVIAS AG, Syneos Health, ICON plc, Frontage Labs, TOXIKON, BioAgilytix Labs, VxP Pharma, Inc., Pace Analytical Services, LLC, Pharmaceutical Research Associates Inc., ALS Limited, Evotec SE, Intertek Group plc, Covance (A Subsidiary of Laboratory Corporation of America), and PPD Inc. (a subsidiary of Thermo Fisher Scientific Inc.) among others
The countries covered in the report are U.S., Canada, and Mexico.